Health & Biotech
At Argent BioPharma, our mission is to revolutionize healthcare through pioneering innovation.
We go beyond traditional disease management by exploring the intricacies of the immune system and harnessing cutting-edge technologies in our research and development endeavors.
Through our commitment to advancing medical science, we aim to reshape the landscape of global healthcare by addressing unmet needs and offering hope to underserved populations worldwide.
Our vision encompasses becoming a leading biopharmaceutical company renowned for groundbreaking medical treatments. By embracing NanoPolyPharmacology, we strive to introduce impactful solutions that elevate standards within the life sciences industry. Our dedication extends to ensuring accessibility to innovative therapies for communities overlooked by conventional medical approaches, thereby bridging healthcare disparities on a global scale.
As we progress on this ambitious path, we invite you to follow our journey and be a part of a transformative shift in healthcare. At Argent BioPharma, we’re not just changing treatments; we’re changing lives.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
MGC Pharma secures UK distributor for its medicinal cannabis treatments
Stockhead TV
StockTalk: Australia’s medicinal cannabis sector is budding again
Health & Biotech
MGC Pharma’s medical spray could be effective COVID-19 treatment; shares spike +40pc
News
10 at 10: These ASX stocks have reached a milestone this morning
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Experts: How to position for the next wave in cannabis
Health & Biotech
Positive results from MGC Pharma’s natural supplement study
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
MGC Pharma expands footprint with cannabis clinic acquisition
Health & Biotech
MGC Pharma receives Australian cannabis research permit
Health & Biotech
MGC Pharma selected for WHO COVID taskforce, shares jump
Health & Biotech
MGC Pharma lands US buyer for the $8.5m sale of its Nutraceuticals business
Health & Biotech
MGC Pharma scoops major Israeli partnership for epilepsy drug
Health & Biotech